Bausch Health Cos Long Term Debt 2010-2024 | BHC

Bausch Health Cos long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Bausch Health Cos Annual Long Term Debt
(Millions of US $)
2023 $21,938
2022 $20,334
2021 $22,654
2020 $23,925
2019 $24,661
2018 $24,077
2017 $25,235
2016 $29,845
2015 $30,265
2014 $15,228
2013 $17,163
2012 $10,535
2011 $6,540
2010 $3,478
2009 $314
Bausch Health Cos Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $21,054
2024-06-30 $21,208
2024-03-31 $21,536
2023-12-31 $21,938
2023-09-30 $21,894
2023-06-30 $20,108
2023-03-31 $20,207
2022-12-31 $20,334
2022-09-30 $20,804
2022-06-30 $21,664
2022-03-31 $23,168
2021-12-31 $22,654
2021-09-30 $22,358
2021-06-30 $23,439
2021-03-31 $23,738
2020-12-31 $23,925
2020-09-30 $24,343
2020-06-30 $24,357
2020-03-31
2019-12-31 $24,661
2019-09-30 $23,466
2019-06-30 $24,023
2019-03-31 $23,924
2018-12-31 $24,077
2018-09-30 $24,433
2018-06-30 $24,858
2018-03-31 $25,266
2017-12-31 $25,235
2017-09-30 $26,216
2017-06-30 $27,648
2017-03-31 $28,198
2016-12-31 $29,845
2016-09-30 $30,386
2016-06-30 $30,773
2016-03-31 $31,303
2015-12-31 $30,265
2015-09-30 $30,176
2015-06-30 $30,290
2015-03-31 $25,898
2014-12-31 $15,228
2014-09-30 $15,584
2014-06-30 $17,059
2014-03-31 $17,148
2013-12-31 $17,163
2013-09-30 $17,044
2013-06-30 $10,447
2013-03-31 $10,327
2012-12-31 $10,535
2012-09-30 $7,423
2012-06-30 $7,356
2012-03-31 $6,851
2011-12-31 $6,540
2011-09-30 $5,188
2011-06-30 $4,529
2011-03-31 $4,699
2010-12-31 $3,478
2010-09-30 $3,114
2010-06-30 $303
2010-03-31 $317
2009-12-31 $314
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.672B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.142B 7.92
Dr Reddy's Laboratories (RDY) India $12.621B 24.15
BridgeBio Pharma (BBIO) United States $4.953B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.975B 26.90
Amphastar Pharmaceuticals (AMPH) United States $1.894B 11.38
Taysha Gene Therapies (TSHA) United States $0.379B 26.43
Personalis (PSNL) United States $0.372B 0.00
Assembly Biosciences (ASMB) United States $0.100B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.008B 0.00
Teligent (TLGT) United States $0.000B 0.00